Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7897619 Heterocyclic modulators of PKB

Patent 7897619 was granted and assigned to Amgen on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Celia Dominguez0

Fang-Tsao Hong0

George E. Wohlhieter0

Guomin Yao0

Holger Monenschein0

James R. Falsey0

James Rider0

John G. Allen0

...

Date of Patent

March 1, 2011

Patent Application Number

12218754

Date Filed

July 16, 2008

Patent Citations Received

US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

0

US Patent 11766436 KRAS G12C inhibitors and methods of using the same

US Patent 11905281 KRAS G12C inhibitors and methods of using the same

0

US Patent 11918584 Combination therapy including a KRAS

0

US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same

0

Patent Primary Examiner

Golam M. Shameem

Patent abstract

The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7897619 Heterocyclic modulators of PKB

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool